Jack Phillips - 22 Jun 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
22 Jun 2021
Transactions value $
-$186,423
Form type
4
Filing time
24 Jun 2021, 18:40:31 UTC
Previous filing
24 May 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise +62,160 +83.98% 136,177 22 Jun 2021 Direct F1
transaction AXDX Common Stock Sale -$186,423 -23,479 -17.24% $7.94 112,698 22 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -62,160 -33.33% $0 124,320 22 Jun 2021 Common Stock 62,160 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 restricted stock units, which vests in three equal annual amounts of 62,160 units starting on June 22, 2021.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.